[Osteomyelitis: germ-spectrum and resistance situation].
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D010019:Osteomyelitis / Q000188:drug therapy / Q000382:microbiology*; D011511:Proteus / Q000472:pathogenicity; D011512:Proteus Infections / Q000188:drug therapy; D011549:Pseudomonas / Q000472:pathogenicity; D011552:Pseudomonas Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000472:pathogenicity; D013291:Streptococcus / Q000472:pathogenicity
D000900:Anti-Bacterial Agents
Osteomyelitis: Erregerspectrum und Resistenzsituation.